Startups
Biothera Pharmaceuticals is a privately held, clinical stage immuno-oncology company developing our proprietary immunotherapy, Imprime PGG, in combination with immune checkpoint inhibitors, or CPIs, for multiple cancer indications. Imprime PGG is a biologic innate immune modulator that activates the immune system and coordinates anti-cancer immune responses that result in increased activation of cancer-specific T cells. Preclinical studies demonstrate that Imprime PGG can enhance the efficacy of anti-cancer immune responses in combination with CPI, tumor-targeting and anti-angiogenic antibodies.
The Company has clinical research agreements with Merck, Genentech and AstraZeneca to evaluate Imprime PGG in combination with CPIs in multiple cancer indications, including metastatic triple negative breast cancer, head and neck cancer and colorectal cancer. Imprime PGG has shown strong evidence of tolerability in clinical trials with more than 500 subjects, including over 400 cancer patients. For more information, visit us at www.biothera.com.
The Company has clinical research agreements with Merck, Genentech and AstraZeneca to evaluate Imprime PGG in combination with CPIs in multiple cancer indications, including metastatic triple negative breast cancer, head and neck cancer and colorectal cancer. Imprime PGG has shown strong evidence of tolerability in clinical trials with more than 500 subjects, including over 400 cancer patients. For more information, visit us at www.biothera.com.
Overview
Location
United States, Minnesota, Eagan
Employees
11-50
Total raised
$3.5M
Founded date
1997
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Biothera raises $3.5M, looking for more | Biothera has raised $3.5 million and the company doesn’t want to stop there, as it aims to push that total to $25 million, according to a Securities and Exchange Commission filing. The 53-employee biotech firm markets itself as “the immune ... |
Reviews 0
FAQ about Biothera Pharmaceuticals, Inc.
When was Biothera Pharmaceuticals, Inc. founded?
Biothera Pharmaceuticals, Inc. was founded in 1997.
How much funding has Biothera Pharmaceuticals, Inc. raised?
Biothera Pharmaceuticals, Inc. has raised $3.5M in total across 1 funding round.
What has the press written about Biothera Pharmaceuticals, Inc.?
Parsers VC has collected 2 articles mentioning Biothera Pharmaceuticals, Inc., among them “Biothera raises $3.5M, looking for more”.
Is Biothera Pharmaceuticals, Inc. still active?
Yes, Biothera Pharmaceuticals, Inc. is active; its latest activity on Parsers VC dates from Apr 13, 2010.